185 related articles for article (PubMed ID: 30608049)
1. Etanercept to Control Inflammation in the Treatment of Complicated Neurocysticercosis.
Nash TE; Ware JM; Coyle CM; Mahanty S
Am J Trop Med Hyg; 2019 Mar; 100(3):609-616. PubMed ID: 30608049
[TBL] [Abstract][Full Text] [Related]
2. TNF-α blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis.
Mahanty S; Orrego MA; Cangalaya C; Adrianzen MP; Arroyo G; Calcina J; Gonzalez AE; García HH; Guerra-Giraldez C; Nash TE;
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006059. PubMed ID: 29190292
[TBL] [Abstract][Full Text] [Related]
3. Natural History of Treated Subarachnoid Neurocysticercosis.
Nash TE; O'Connell EM; Hammoud DA; Wetzler L; Ware JM; Mahanty S
Am J Trop Med Hyg; 2020 Jan; 102(1):78-89. PubMed ID: 31642423
[TBL] [Abstract][Full Text] [Related]
4. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
Keiser PB; Nash TE
Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
Kaur S; Singhi P; Singhi S; Khandelwal N
Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
[TBL] [Abstract][Full Text] [Related]
6. Current approaches to cysticidal drug therapy for neurocysticercosis.
Del Brutto OH
Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
[TBL] [Abstract][Full Text] [Related]
7. Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
Cangalaya C; Bustos JA; Calcina J; Vargas-Calla A; Mamani J; Suarez D; Arroyo G; Gonzalez AE; Chacaltana J; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005624. PubMed ID: 28575043
[TBL] [Abstract][Full Text] [Related]
8. Medical management of neurocysticercosis.
Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.
Kim SK; Wang KC; Paek SH; Hong KS; Cho BK
Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021
[TBL] [Abstract][Full Text] [Related]
10. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
Romo ML; Carpio A; Kelvin EA
J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
[TBL] [Abstract][Full Text] [Related]
11. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Garcia HH; Del Brutto OH;
Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of neurocysticercosis: a review].
Nogales-Gaete J; Arriagada C; Salinas R
Rev Med Chil; 2006 Jun; 134(6):789-96. PubMed ID: 17130956
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
Jung-Cook H
Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
[TBL] [Abstract][Full Text] [Related]
15. Lumbosacral Radiculopathy as the Clinical Presentation of Neurocysticercosis.
Pérez-Jacoiste Asín MA; Calleja-Castaño P; Hilario A
Am J Trop Med Hyg; 2020 Jun; 102(6):1166-1167. PubMed ID: 32519649
[No Abstract] [Full Text] [Related]
16. Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
Arroyo G; Bustos JA; Lescano AG; Gonzales I; Saavedra H; Rodriguez S; Pretell EJ; Bonato PS; Lanchote VL; Takayanagui OM; Horton J; Gonzalez AE; Gilman RH; Garcia HH;
Clin Infect Dis; 2019 Nov; 69(11):1996-2002. PubMed ID: 30715265
[TBL] [Abstract][Full Text] [Related]
17. [About an autochtonous case of neurocysticercosis in Mali].
Maïga Y; Diallo M; Bouteille B; Konate A; Diarra M; Maïga M; Marjolet M
Bull Soc Pathol Exot; 2009 Oct; 102(4):211-4. PubMed ID: 19950534
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
Sotelo J; Jung H
Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
[TBL] [Abstract][Full Text] [Related]
19. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
Matthaiou DK; Panos G; Adamidi ES; Falagas ME
PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068
[TBL] [Abstract][Full Text] [Related]
20. Therapy for neurocysticercosis.
Takayanagui OM
Expert Rev Neurother; 2004 Jan; 4(1):129-39. PubMed ID: 15853623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
